Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quotient Clinical Completes Expansion | Contract Pharma

What are you searching for?

Sign in
Breaking News

Quotient Clinical Completes Expansion

Quotient Clinical, a business unit of Quotient Bioresearch, has completed a major expansion of its clinical facilities in Nottingham, UK.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quotient Clinical, a business unit of Quotient Bioresearch, has completed a major expansion of its clinical facilities in Nottingham, UK. The expansion includes a 50% increase in bed capacity and a dedicated sample processing lab for human ADME studies. The new facilities have been inspected and approved for use by the UK regulatory authority, the Medicines and Healthcare products Regulatory Agency (MHRA), and have been awarded Supplementary Accreditation.

The facilities will operate under Quotient’s Synthesis-to-Clinic platform in support of human ADME studies, reinforcing the company’s provision of 14C-enabled drug development services including Phase 0 microdose, ivMicrotracer, and human metabolism studies.

Mark Egerton, M.D. of Quotient Clinical, said,“In parallel with the recent expansion of our Pharmaceutical Sciences laboratory and GMP drug product manufacturing facility, the completion of this clinical expansion is another milestone in the development of our business. It underlines the strength of our Synthesis-to-Clinic platform and the benefits it brings to our global client base. Our expanded facilities will assist the continued development of our services, supporting our customers in taking new and innovative approaches in early drug development.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics